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Smoking as a Cofactor for Causation of
Chronic Pancreatitis
A Meta-Analysis
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Objectives: To assess the evidence for tobacco smoking as a risk factor
for the causation of chronic pancreatitis.
Methods: We performed a meta-analysis with random-effects models
to estimate pooled relative risks (RRs) of chronic pancreatitis for cur-
rent, former, and ever smokers, in comparison to never smokers. We also
performed dose-response, heterogeneity, publication bias, and sensitivity
analyses.
Results: Ten case-control studies and 2 cohort studies that evaluated,
overall, 1705 patients with chronic pancreatitis satisﬁed the inclusion
criteria. When contrasted to never smokers, the pooled risk estimates
for current smokers was 2.8 (95% conﬁdence interval [CI], 1.8Y4.2)
overall and 2.5 (95% CI, 1.3Y4.6) when data were adjusted for alcohol
consumption. A dose-response effect of tobacco use on the risk was
ascertained: the RR for subjects smoking less than 1 pack per day was
2.4 (95% CI, 0.9Y6.6) and increased to 3.3 (95% CI, 1.4Y7.9) in those
smoking 1 or more packs per day. The risk diminished signiﬁcantly after
smoking cessation, as the RR estimate for former smokers dropped to a
value of 1.4 (95% CI, 1.1Y1.9).
Conclusions: Tobacco smoking may enhance the risk of developing
chronic pancreatitis. Recommendation for smoking cessation, besides al-
cohol abstinence, should be incorporated in the management of patients
with chronic pancreatitis.
Key Words: chronic pancreatitis, smoking, cigarette, nicotine,
alcohol, meta-analysis
(Pancreas 2010;39: 1205Y1210)
D uring the past 2 decades, several experimental evidencesindicated that cigarette/nicotine smoking induces marked
pathological and functional changes in the exocrine pancreas.1
In humans, serum pancreatic enzymes after intravenous secre-
tin injection increase substantially in smokers, but not in non-
smokers.2 Mechanisms by which nicotine induces such changes
are mediated via signal transduction pathways in the pancreatic
acinar cell, leading to enhanced levels of intracellular calcium
release1 and/or impairment of pancreatic blood ﬂow.3 Yet, only
few pancreatic specialists advise alcoholic patients with chronic
pancreatitis for smoking cessation treatment, besides alcohol
abstinence.
Cigarette smoking has been suggested as the single most
important factor for the development of pancreatic cancer, caus-
ing a 75% increase in the risk compared with nonsmoking.4
In contrast, epidemiological data linking cigarette smoking to
the development of chronic pancreatitis offer conﬂicting con-
clusions.5Y20 Most studies indicate smoking as one of the can-
didate susceptibility factors for pancreatitis,5Y7,10Y17,20 whereas
others have denied such an association.8,9,18 The close inter-
action between tobacco consumption and alcohol intake21 with
heavy drinkers often being heavy smokers22,23 renders prob-
lematic to ascertain the relative pathogenic role of the 2 factors
in tissue injury. Moreover, methodological differences among
existing epidemiological studies cast doubt on the ﬁndings in
this topic. Many of the positive reports have been confounded
by the retrospective nature of data collection, which impacts
signiﬁcantly on the ability to accurately assess alcohol intake
or cigarette-smoke exposure.24 Furthermore, the lack of appro-
priate controls is crucial for any study examining individual
susceptibility to alcoholic pancreatitis: it has been argued that
the best comparison for such studies must be between alco-
holics with the disease and alcoholics without the disease so
that the index and the control groups differ only in 1 variable,
that is, the presence or absence of pancreatitis.8,25 Unfortunately,
numerous studies in the literature have used only the general
population as controls, making the interpretation of results
controversial.7,12,14,19,20
The current review focuses on important epidemiological
observation linking tobacco smoking to chronic pancreatitis
development and provides insightful interpretation of what is
known. The aims of this study were to provide a statistical
evaluation using a meta-analytic approach of the strength of the
association between tobacco smoking and chronic pancreatitis
and to assess whether the association depends on study char-
acteristics such as the control population, study designs, or level
of exposure.
MATERIALS AND METHODS
Search Strategy, Inclusion Criteria, and Data
Abstraction
We searched PubMed from 1966 to July 15, 2009, for the
following terms: ([smoke OR cigarette OR tobacco OR smoking]
AND [(chronic pancreatitis OR alcoholic chronic pancreatitis
OR pancreatitis)]. Our search was restricted to human studies
published in English language. We searched the reference lists
of articles and reviews on the topic to identify additional relevant
studies.
Only reports complying with the following inclusion cri-
teria were included in the meta-analysis. First, studies should
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contain the minimum information necessary to estimate the
relative risk (RR) associated with tobacco smoking and a cor-
responding measure of uncertainty (ie, 95% conﬁdence interval
[CI], SE, or P value of the signiﬁcance of the estimate). Com-
parisons of interest were current versus never smokers, former
versus never smokers, and ever versus never smokers. Second,
studies should be independent: in case of multiple reports on the
same population, we considered the estimates from the most
informative report. When available, we used adjusted estimates.
Three of us (A.A., P.L.A., and E.B.) independently abstracted
the data, and we resolved discrepancies by committee.
Data Analysis
The RR was used as a measure of the association between
cigarette smoking and pancreatitis. For case-control studies,
odds ratios were used as estimates of the RR. We used random-
effects models to estimate pooled RRs. Homogeneity of effects
across studies was assessed using the W2 statistic26,27 and the I2
statistic,28 which represents the percentage of total variation
across studies that is attributable to heterogeneity rather than
to chance. Subgroup analyses and metaregression models were
carried out to investigate potential sources of between-study
heterogeneity, such as sex or study design. When several risk
estimates were present in a single study (ie, separate estimates
for men and women), we adjusted the pooled estimates for in-
trastudy (or within-study) correlation.27 Publication bias was
evaluated by funnel plots and quantiﬁed by the Egger’s test.29
Analyses were performed with the SAS software (version 8.2;
SAS, Cary, NC). All P values were 2-sided.
RESULTS
Study Identiﬁcation and Selection
Our search returned 253 citations. Title and abstract review
resulted in exclusion of 237 studies. This left 16 publications
on the topic of interest,5Y20 and full text was retrieved for de-
tailed evaluation. Four studies11,13,16,17 were excluded because
of multiple reports on the same setting of patients,16,17 of pool-
ing in a single category former smokers and never smokers,11
or because the comparison group included patients with mild
form of alcoholic chronic pancreatitis and moderate smokers
were aggregated with never smokers as the reference group.13
We included in the meta-analysis 12 studies published be-
tween 1982 and 2009,5Y10,12,14,15,18Y20 involving a total of 1705
chronic pancreatitis patients. The number of patients in each
study ranged from 39 to 540. Overall, 1235 (72%) were males.
Table 1 shows selected traits of the total study population and
of the chronic pancreatitis cases.
Results From the Meta-Analysis
Results are outlined in Table 2 and illustrated as forest plots
in Figures 1 to 3. When contrasted to never smokers, pooled
risk estimates were 2.8 (95% CI, 1.7Y4.8) for ever smokers based
on 12 studies, 2.8 (95% CI, 1.8Y4.2) for current smokers based on
8 studies, and 1.4 (95% CI, 1.1Y1.9) for former smokers based on
8 studies. We found evidence of heterogeneity among the studies
for ever smokers (P G 0.01 and I2 72% for all estimates; Table 2)
but not for current and former smokers. Risk estimates for ever
smokers maintained some heterogeneity even in the subgroup
analyses. The meta-analytical results did not differ when case-
control studies and cohort studies were analyzed separately for
each of the 3 smoking categories. When limiting the analysis
to studies that controlled for alcohol consumption or included
only alcoholics without chronic pancreatitis among controls, the
alcohol-adjusted RR estimates were still signiﬁcant despite the
lower number of studies providing such data: compared with TA
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FIGURE 1. Forest plot of the RR of developing chronic pancreatitis for ever smokers versus never smokers. The size of each square is
proportional to the study’s weight (inverse of variance). Studies are sorted by publication year and identiﬁed by, from left to right:
ﬁrst author, publication year, sex (M indicates males; F, females; MF, males and females), category of exposure (ever, current, or former),
and amount of exposure. When we limited the analysis to studies reporting alcohol-adjusted estimates (excluding Rothenbacher14
and Bourliere7), we obtained a pooled estimate of 2.7 (95% CI, 1.5Y4.7).
FIGURE 2. Forest plot of the RR of developing chronic pancreatitis
for current smokers versus never smokers. The size of each
square is proportional to the study’s weight (inverse of variance).
Studies are sorted by publication year and identiﬁed by, from left
to right: ﬁrst author, publication year, sex (M indicates males;
F, females; MF, males and females), and, where required, amount
of exposure. When we limited the analysis to studies reporting
alcohol-adjusted estimates (excluding Rothenbacher14 and
Yadav20), we obtained a pooled estimate of 2.5 (95% CI, 1.3Y4.6).
FIGURE 3. Forest plot of the RR of developing chronic pancreatitis
for former smokers versus never smokers. The size of each
square is proportional to the study’s weight (inverse of variance).
Studies are sorted by publication year and identiﬁed by, from
left to right: ﬁrst author, publication year and sex (M indicates
males; F, females; MF, males and females). When we limited the
analysis to studies reporting alcohol-adjusted estimates (excluding
Rothenbacher14 and Yadav20), we obtained a pooled estimate
of 1.5 (95% CI, 0.9Y2.5).
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never smokers, the RR estimates were 2.7 (95% CI, 1.5Y4.7)
for ever smokers, 2.5 (95% CI, 1.3Y4.6) for current smokers, and
1.5 (95% CI, 0.9Y2.5) for former smokers.
Five studies5,10,12,18,19 reported stratiﬁcation of patients for
the amount of tobacco use. Among current smokers, we found
a dose-response relationship between the amount of tobacco
smoked and the risk of developing chronic pancreatitis: the RR
for patients smoking less than 1 pack per day was 2.4 (95% CI,
0.9Y6.6) and increased to 3.3 (95% CI, 1.4Y7.9) in those smok-
ing 1 or more packs per day. Analysis by funnel plots and
Egger’s test suggested that publication bias was not a problem
in the context of our study (results not shown).
As alcoholic chronic pancreatitis is predominantly a male
disease,30,31 we performed a subset analysis to clarify whether
the risk was higher among male patients. We found signiﬁcantly
raised RR estimates for ever and current smokers in compari-
son to never smokers: RR of 4.2 (95% CI, 2.3Y7.8) and RR of
4.4 (95 CI, 1.5Y12.8) based, respectively, on 9 and 5 studies;
the association lost statistical signiﬁcance for former smokers
(RR, 1.6; 95% CI, 1.0Y2.7) based on 5 studies.
DISCUSSION
Smoking is an established risk factor for many forms of
cancer.32 In particular, tobacco use approximately doubles the
risk of pancreatic cancer4,32,33 and has been already identiﬁed
as a risk factor for the susceptibility to chronic pancreatitis in
addition to alcohol abuse.5Y20 Yet, only few physicians advice
smoking cessation when caring for either patients with alcohol
addiction or those with an established chronic pancreatitis sec-
ondary to alcohol abuse. Plausible explanation for this paradox
relates to either the inconsistency in the reported association
with some negative reports8,14,18 and to the confounding effect
of alcohol consumption, as cigarette smoking is often an insep-
arable addiction in most alcoholics.21Y23 Therefore, it has been
hard to separate the role of smoking from the effect of alcohol
in causation of chronic pancreatitis.
The current meta-analysis supports and strengthens the
evidence on the association between cigarette smoking and the
risk for chronic pancreatitis: our analysis based on 12 inde-
pendent studies has shown that, overall, tobacco use confers a
2- to 3-fold increased risk of developing a chronic pancreatitis
in comparison to alcoholics or population-based controls who
never smoked. Moreover, the likelihood of developing chronic
pancreatitis was found to be proportional to the amount of
tobacco use, suggesting that smoking exerts a dose-related
effect on initiating pancreatic injury. Indeed, the pooled RR
was 3.3 (95% CI, 1.4Y7.9) for smokers of 1 or more packs per
day and was lower in those smoking less than 1 pack per day
(RR, 2.4; 95% CI, 0.9Y6.6). Of note, the strength of the
evidence is much stronger than the reported estimates for
smoking as a risk factor for pancreatic adenocarcinoma.4,32,33
The validity of the relationship between smoking and chronic
pancreatitis is further highlighted by the lower risk after
smoking cessation: compared with never smokers, the risk in
current smokers seemed higher than in former smokers, with
respective pooled RR estimates of 2.8 (95% CI, 1.8Y4.2) and
1.4 (95% CI, 1.1Y1.9). Risk estimates for ever smokers were
heterogeneous, whereas for current and former smokers they
were not. This could be due to the fact that the category of ever
smokers could contain, by deﬁnition, a great variety of types
of smokers, and often the studies did not supply the details of
exposure.
A strong argument against the role of tobacco smoking in
the initiation of alcohol-induced injury to the pancreatic pa-
renchyma was raised by Haber et al,8 who argued that the
presence of 2 known factors, that is, alcohol and tobacco, would
render difﬁcult to ascertain the relative pathological contribu-
tion of either factor in tissue damage. A major strength of our
study is to have controlled the RR estimates for alcohol con-
sumption. In the event alcohol consumption might act as the
sole or the predominant factor in the causation of chronic pan-
creatitis, one would expect that the risk observed for smoking
weakens. On the contrary, we observed no variation in the
magnitude of the risk estimates when we limited the analysis to
the 10 studies5,6,8Y10,12,15,18Y20 reporting alcohol-adjusted RR
estimates or presenting data in alcoholics only. Although the risk
was higher for current than for former smokers, the increasing
risk with increasing levels of tobacco consumption and the sta-
bility of the risk estimates after adjustment for alcohol provide
strong support for the role of tobacco smoking in the develop-
ment of alcoholic chronic pancreatitis; it is still possible that
residual confounding with alcohol exists and accounts for part of
the association observed with tobacco smoking.
The comparisons between subjects with and without
chronic pancreatitis would be expected to differ markedly
from comparisons using controls drawn from the general
population or subjects hospitalized for reasons other than
those related to alcohol or smoking. Indeed, RR did not differ
when controls were extracted from the general, healthy pop-
ulation or from hospitalized patients or when only alcoholics
were included among controls.
Other issues concerning our analysis merit consideration.
Most cases enrolled in the original, selected studies were
patients with chronic pancreatitis, but a few cases of acute,
relapsing/recurrent pancreatitis were also included in some
studies5,12,18 and could have biased the association. In fact,
much less evidence exists on the effect of tobacco smoking on
acute or recurrent pancreatitis. Whereas recently Lindkvist
et al34 found that smoking was associated with the incidence
of acute pancreatitis in a dose-response manner, Pelli et al35 did
not ﬁnd smoking to be a risk factor for recurrent episodes after
the ﬁrst attack of acute alcoholic pancreatitis.
Although the number of studies included in this meta-
analysis is limited and the study population characteristics and
the assessment of the exposure to tobacco and alcohol often
inadequate to obtain conﬁdent risk estimates, a series of studies
provide further support to the role of tobacco smoking on
pancreatic damage in patients with chronic pancreatitis. Among
patients with chronic alcoholic and idiopathic pancreatitis,
tobacco smoking seems to be associated with worsening of the
disease, accelerating in particular the development of calciﬁca-
tions.24,36,37 Among patients with hereditary pancreatitis who
face an elevated risk of being diagnosed with pancreatic ade-
nocarcinoma, smoking seems to advance the age of cancer
diagnosis by approximately 2 decades.38 Although pancreas
cancer risk is not associated with one of the speciﬁc genetic
mutations leading to hereditary pancreatitis,39 it seems to be re-
lated to the longstanding inﬂammation of the pancreas in these
patients and be exacerbated by exposure to tobacco smoke.
Although a meta-analysis represents a powerful instrument
to resolve eventually conﬂicting research results, increasing the
effective sample size by pooling many studies and offering the
possibility to explore sources of heterogeneity, it, however,
suffers from the quality of the data analyzed. We recognize
that the current meta-analysis is based on a series of reports in
which alcohol and smoking history were poorly recorded, but
in our view, it should be the basis for the planning of future
research, using more objective measures of lifetime alcohol and
tobacco consumption.
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In conclusion, the present investigation overcomes some
of the limitations that may have hindered the detection of cig-
arette smoking as a trigger factor for chronic pancreatitis in
previous studies. We have shown that cigarette smoke approx-
imately doubles the risk of developing chronic pancreatitis,
with a clear dose-response relationship with the number of cig-
arettes smoked per day. The association was still present after
adjustment for alcohol consumption, and the risk was substan-
tially lower among former than current smokers. The evidence
presented offers solid backing for changing the current standard
of care of alcoholic pancreatitis that includes the rehabilitation
for alcoholism but not cessation of smoking. It may also serve
for planning programs for the primary prevention of chronic
pancreatitis by a combined effort directed toward abstaining not
only from alcohol, but also from smoking.
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